Indicators for Monitoring National Drug Policies: ANNEX 1: Data collection forms: Summary Form 1 - National drug policy background information

Table of Contents

	ACKNOWLEDGEMENTS
	CHAPTER I: Introduction
		Why indicators of national drug policies are needed
		How to use the manual
		Who should use the manual
		How to use the indicators
		How to apply the indicators
		How the results can be used
	CHAPTER II: Development of the manual
		Methodology
	CHAPTER III: Model lists of indicators
		Background information
		Structural indicators
		Process indicators
		Outcome indicators
	CHAPTER IV: Methodology for indicator calculation
		Organizing the data collection
		Collecting data
		Analysis and reporting
		Conducting surveys
		Calculating the value of a basket of drugs
	CHAPTER V: Detailed presentation of indicators
		Structural indicators
		Process indicators
		Outcome Indicators
	ANNEX 1: Data collection forms
		Data Collection Form 1 - Private drug outlets
		Data Collection Form 2 - Public sector drug outlets
		Data Collection Form 3 - Health facilities/prescribers
		Data Collection Form 4 - Remote health facilities
		Summary Form 1 - National drug policy background information
		Summary Form 2 - National drug policy structural indicators
		Summary Form 3 - National drug policy process indicators
		Summary Form 4 - National drug policy outcome indicators
	ANNEX 2: Glossary
	ANNEX 3: Table of random numbers
	BACK COVER

* Do not forget to indicate the year for which the information is collected and the source.

1. Country information

Population data

BG1: Total population
BG2: Average annual growth of the population (%)
BG3: Percentage of the total population living in urban areas
BG4: Life expectancy (years)

Economic data

BG5: GNP per capita (US$)
BG6: Average annual rate of inflation (%)

2. Health information

Health status data

BG7: Infant mortality rate (per 1,000 live births)
BG8: Maternal mortality rate (per 100,000 live births)

BG9: Top five causes and rate of infant morbidity

BG10: Top five causes and rate of infant mortality

BG11:Top five causes and rate of adult morbidity

BG12:Top five causes and rate of adult mortality

Health system data

BG13: Total number of prescribers
BG14: Total public health budget
BG15: Total value of international aid for the health sector
BG16: Total health expenditure (public + households + international aid)

3. Drug sector information

Economic data

BG17: Total public drug expenditure
BG18: Total value of international aid for drugs (cash + kind)
BG19: Total drug expenditure (public + households + international aid)
BG20: Total value of local production (ex-factory price) sold in the country
BG21: Total value of drug imports (CIF)
BG22: Total value of drugs under generic name (CIF price for imported drugs and ex-factory price for locally produced drugs) sold in the country

Human resources

BG23: Total number of pharmacists
BG24: Total number of pharmacy technicians or other aides/assistants

Drug sector organization

BG25: Total number of drug manufacturing units in the country
BG26: Total number of wholesalers in the country
BG27: Total number of pharmacies and drug outlets in the public sector (including health facilities and hospitals that dispense drugs)
BG28: Total number of pharmacies and drug outlets in the private sector
BG29: Total number of private pharmacies and drug outlets in the three major urban areas

Number of drugs

BG30: Total number of registered drugs (in dosage forms and strengths)
BG31: Total number of drugs on the national essential drugs list (in INN)